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 Enhancers are critical for the activation of V(D)J recombination 
 The small murine Ig locus is ideal for systematically mapping 
regulatory enhancers 
 Using BAC constructs in transgenic mice we identify HS1 as a key 
enhancer 
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Enhancers are essential for long range chromatin opening and the activation of 
V(D)J recombination at the antigen receptor loci. The murine immunoglobulin 
lambda light chain locus is a duplicated locus and, using a bacterial artificial 
chromosome spanning the 3’ half of the locus to generate transgenic mice, we 
have identified a critical enhancer element for lambda locus recombination. 
Four hypersensitive sites had been previously mapped downstream of the JC1 
gene segment (HS1-4). Systematic deletion of these individual hypersensitive 
sites showed that HS1, which forms the major part of the transcription 
enhancer, E3-1, is essential for Ig recombination and that it also helps to 






V(D)J recombination generates a highly diverse antigen receptor repertoire but 
since the reaction involves the breakage and rejoining of DNA, it must be very 
tightly controlled. Recombination is initiated by just two lymphocyte-specific 
proteins, RAG1 and RAG2, that bind to conserved recombination signal 
sequences (RSSs) that lie adjacent to all V, D and J gene segments in the 
antigen receptor loci. Despite using the same proteins and conserved RSSs, 
immunoglobulin and T cell receptor genes rearrange specifically in B and T 
cells, respectively and only at distinct stages of lymphocyte development. 
 
The generation of an accessible chromatin structure at the RSSs is central to 
this regulation (reviewed by [1]) and knock-out studies have shown that tissue-
specific enhancers play an essential role in regulating this accessibility by 
restricting it to the correct cell and the correct stage of lymphocyte development 
[2]. Recombination enhancers have been identified for most immunoglobulin 
and T cell receptor loci and are often identical to the enhancers that upregulate 
transcription of the rearranged gene [3]. However, since some recombination 
enhancers function redundantly [4], it is difficult to confidently identify all the 
regulatory enhancers within a given locus.  
 
The murine Ig light chain locus is the smallest antigen receptor locus and thus 
is a good model with which to systematically analyse the critical regulatory 
elements. It spans only 240 kb on chromosome 16 and contains two gene 
clusters that appear to have arisen by duplication (reviewed by [5]).  Each 
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cluster contains 1-2 variable gene segments followed by two joining/constant 
(J/C) regions, in the order V2-Vx-JC2-JC4--V1-JC3-JC1 [6, 7]; since JC4 
is a pseudogene, the locus undergoes only four main rearrangements: V1-J1, 
V2-J2 Vx-J2 and V1-J3 that occur in the ratio 3:2:2:1 [8, 9].  However, V2 
can also recombine with JC1 or JC3, albeit infrequently [10]. These rare 
rearrangements suggest that at least some regulatory elements lie either 5’ of 
V2 or 3’ of JC1 since recombination between V2 and J1 removes the 
intervening DNA.  
 
Early studies to identify these regulatory elements relied on DNAse I 
hypersensitive mapping in B and T cell lines [11]. This identified a single 
hypersensitive site 15.5 kb downstream of JC4 that appeared to be B-cell 
specific and coincided with a strong transcriptional enhancer (E2-4).  
Rearrangement of V2 to JC3 or JC1 deletes E2-4.  However, a second 
strong enhancer was mapped 35 kb downstream of C1, which cannot be 
eliminated by any Ig gene rearrangements (Figure 1A); this second Ig 
transcriptional enhancer (E3-1) is 90% homologous to E2-4 [11].  
 
Subsequently, more hypersensitive sites were identified downstream and within 
5 kb of E3-1 [12], namely, HS1, HS2, HS3 and HS4 where E3-1 is identical to 
HS1 and HS2 (Figure 1A). Notably, generation of transgenic mice by co-
injection of two overlapping cosmids, which integrated with the same 
organisation as the endogenous locus, demonstrated that inclusion of the 
hypersensitive site cluster HS1 to HS4, results in high level expression of Ig1 
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mRNA in B cells. This suggests that these downstream hypersensitive sites 
potentially behave as a locus control region (LCR) by conferring position 
independent, copy number dependent expression of the linked gene [12].   
 
The enhancers that regulate Ig recombination are largely unknown but the 
transcriptional enhancers (E2-4 and E3-1) as well as HS3 and HS4 are good 
candidates. Most Ig rearrangement occurs between V1 and JC1 [13] and, 
since theIg locus is duplicated [5], a reasonable hypothesis is that at least 
some of the regulatory information is present in the 3’ half of the locus. 
Therefore, the regulatory elements were analysed using a BAC construct that 
encodes the 3’ half of the Iglocus from the hypersensitive site 5’ of V1 (hsV1) 
to the four hypersensitive sites that lie downstream of JC3 (HS1-4; Figure 1B). 
Transgenic mice were generated and recombination examined in mice carrying 
the wild type BAC and those carrying deletions of each of the downstream 
hypersensitive sites. These studies identified HS1 as a critical element in the 




Materials and methods 
Modification of BACs by homologous recombination. 
The BAC rp23-247i11 was obtained from CHORI (Children’s Hospital Oakland 
Research Institute) and modified by homologous recombination in DY380 cells 
as described [14]. Pools containing the targeted clone were screened by PCR 
using the primers listed in Supplementary Table 1. 
T7 and Sp6 deletion cassettes. 
Mouse sequences from the T7-proximal region of rp23-247i11 were removed 
using a deletion cassette that contained approximately 200 bp of homology 5’ of 
the region to be deleted fused to ~200 bp 3’ of the deletion site. The cassette 
was generated by two separate PCR reactions using 100 ng of rp23-247i11 as 
template and primers T7-HindIII plus T7-NotI and primers T7-3’HS/NotI plus 
3’HS (Supplementary Table 1). The amplified products were used as templates 
in the second round of PCR with primers T7-HindIII and 3’HS. Following 
homologous recombination in DY380 cells, recombinants were screened by 
PCR using primers, 3’HSdel and T7 BAC.  
DNA was deleted from the SP6 end of the clone, using a deletion cassette 
generated as described above except primers Sp6-PvuII plus Sp6-NotI and 
Sp6-5’HS/NotI plus 5’HS were used in the first round and primers Sp6-PvuII 
plus 5’HS in the second round of PCR. Positive recombinants were screened 




cMyc insertion cassette 
The insertion cassette has a 39 bp cMyc tag between ~200 bp regions of 
homology that lie 5’ and 3’ of the Xho I site in C1; it was generated by two 
rounds of PCR, as described in Supplementary Table 2 and inserted into the 
T7/Sp6 BAC. Recombinants were screened using C1-F2 and cMycR 
primers (Supplementary Tables 1 and 3). 
The HS1, HS2, HS3 and HS4 deletion cassettes  
Deletion cassettes for DNAse I hypersensitive sites 1, 2, 3 and 4 were 
generated by PCR using 100 ng of rp23-247i11 template and primers A + C or 
B + D for the first round of PCR (Supplementary Tables 1 and 2) and primers A 
and D for the second round. The PCR reactions used to screen the recombinant 
BACs are given in Supplementary Tables 2 and 3. 
Recombinant BAC DNA was prepared using a Qiagen maxi-prep kit and verified 
by sequencing.  
 
Isolation of BAC DNA for microinjection 
Prior to microinjection, BAC vector sequence was removed by Not I digestion. 
The insert (~70 kb) was purified via a 5-25% sodium chloride gradient in a 
Beckman SW40 rotor at 37 000 rpm for 200 minutes at 4C. The peak DNA 
fraction was precipitated, washed with 70% ethanol and resuspended in H2O 
(~50 g/ l) prior to microinjection. All transgenic mouse work was performed 
according to the UK Home Office guidelines with the necessary ethical approval 
and relevant UK licences. 
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Detection of V1-JC1 rearrangement at endogenous and transgenic loci 
V1-J1 products derived from the endogenous and transgenic loci were 
amplified in the same reaction by semi-quantitative PCR using 500 ng of spleen 
DNA and primers V1-2/F and C1-2/R (Supplementary Table 4). To 
distinguish the products from each locus, the PCR products were digested with 
Xho I. Following separation on a 0.8% agarose gel, the DNA was Southern 
blotted and hybridised at 60ºC overnight to the C1 F3-R3 probe.   
 
Detection of V1-JC1 rearrangement at transgenic and endogenous Ig 
loci by nested PCR. 
Recombination of BAC constructs was detected via nested PCR, using a primer 
specific to the transgene, cMyc/F with V1-2/F (Supplementary Table 4) and 
50-400 ng of spleen DNA as template in the first round of PCR (15 cycles). An 
aliquot (0.8 l) from this first round was used as template in the second round of 
PCR (25 cycles) using nested primers (V1-Nested-F and C1-Nested-R). The 
recombination products were detected by Southern blotting, using the C1 F3-
R3 probe.  
To detect rearrangement of the endogenous locus, the same amount of DNA 
was amplified by 25 cycles of semi-quantitative PCR using primers V1-int/F 
and C1-insert/R (Supplementary Table 4). The products were co-




Analysis of recombination in CD43+ and CD43- B cells 
CD43+/CD19+ and CD43-/CD19+ cells were purified from femurs of transgenic 
mice by flow cytometry; DNA was prepared and the levels normalised between 







Generation of a BAC spanning the 3’ half of the Ig locus 
To test which elements regulate Ig recombination, mouse genomic sequences 
were deleted from the original BAC, rp23-247i11, to generate the BAC 
T7/SP6 that carries the 3’ half of the lambda locus from upstream of the 
V1 promoter to 3 kb downstream of HS4 (Figure 1B). To distinguish this BAC 
from the endogenous Ig locus, a cMyc tag (39 bp) was introduced into the C1 
constant region so that it inserted into, and destroyed, the Xho I site; this 
generated the BAC, C1-T (Figure 1B).  
 
Analysis of recombination in transgenic mice carrying the wild type BAC 
construct 
Hypersensitive sites 1-4 potentially have LCR activity [12] and we first wanted to 
determine whether collectively they are able to trigger chromatin opening for 
V(D)J recombination. Therefore, transgenic mice were generated with the 
tagged BAC construct, C1-T. Since the Ig locus normally rearranges in only 
5% of B cells, these founder transgenic mice were crossed with CT mice, in 
which the Ig constant region has been deleted [16].  Heterozygous CT mice 
have two fold more+ producing cells than Ig wild-type littermates [16] and 
thus V1-JC1 recombination should be more apparent in these crosses.   
 
The level of recombination of the BAC transgene was then compared to that of 
the endogenous locus using spleen DNA from F1 mice and PCR primers 
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specific to V1 and downstream of the Xho I site in C1 (Figure 2A). Since the 
cMyc tag disrupts the Xho I site, PCR products derived from the endogenous 
and transgene loci were distinguished by digestion with Xho I. We find that the 
BAC transgene undergoes recombination, albeit at a lower level than that of the 
endogenous locus by 3 to 6 fold (Figures 2B and 2C).  Thus, whilst the 
regulatory elements within the BAC are sufficient to activate Ig recombination, 
at least one additional element appears to be required for the full level of Ig 
rearrangement.    
 
Transgenic mice with deletions of the downstream hypersensitive sites. 
To determine which of the four downstream hypersensitive sites stimulate Ig 
recombination, each hypersensitive site was separately deleted from the BAC 
construct using deletion cassettes that were generated by fusing up to 200 bp of 
sequence 5’ of the region to be deleted with sequences 3’ of the region via 
PCR. The enhancer, E3-1, has been previously found to contain two DNAse I 
hypersensitive sites that lie either side of a Bgl II restriction site ([17] and N. 
Dillon, personal communication).  Therefore, two deletions were made:  Firstly, 
the active transcriptional enhancer region (5’ of the Bgl II site), that 
encompasses all the previously characterised E3-1 transcription factor binding 
sites [18], was successfully deleted by removing 564 bp (HS1).  A 164 bp 
deletion of the second hypersensitive site, HS2 was next made to remove DNA 
3’ of the Bgl II site.  In addition, hypersensitive sites HS3 and HS4 were 
separately eliminated by deleting 626 and 372 bp, respectively. These deletions 
correspond to the size required to remove the main transcription factor binding 
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sites in each hypersensitive site, as determined from in vitro footprinting studies 
for HS1 [18] and HS4 (Supplementary Figure 1) and/or the published size of the 
hypersensitive site [12]. Transgenic mice were generated using these BAC 
constructs and the founders crossed with CT mice as above. 
 
Recombination of the transgene determined by nested PCR. 
Next, we measured the level of recombination and, to ensure that we could 
detect recombination even if it is very low, we adopted a more sensitive, nested 
PCR assay. Since we needed to compare the level of recombination among 
different samples, we optimised the PCR to ensure that the final product was 
proportionate to the input DNA and found this is indeed the case for the wild 
type BAC transgenes (Supplementary Figure 2A and B) and the endogenous 
locus (Supplementary Figure 2C) over the range of 50 to 400 ng input DNA. 
Moreover, we verified that this assay is quantitative at the typical transgene 
copy number of the mice carrying BACs with deleted hypersensitive sites 
(Supplementary Figure 2B and Supplementary Table 5). 
 
HS1 is essential for recombination 
Recombination was then analysed in the BAC wild-type and mutant lines, 
initially using 50 ng of input DNA in the first round of the PCR.  In all three 
transgenic lines in which HS1 had been deleted (HS1), recombination of the 
transgene was eliminated (Figure 3A, left). To further test if HS1 is indeed 
critical for recombination, the assay was repeated using increased amounts of 
input DNA (200 and 400 ng).  Once again, no recombination of the transgene 
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was detected in any of the HS1 transgenic lines (Figure 3A, right); together, 
these data imply that HS1 is required for recombination.   
 
In contrast, deletion of any of the other three hypersensitive sites resulted in 
recombination in at least one of the transgenic lines tested using 50 ng of input 
DNA (Figures 3B and 3C, left and Supplementary Table 5). This suggests that 
HS1 is the only critical element for recombination. To further verify that 
recombination was indeed possible in the absence of any of the other 
hypersensitive sites, we used increased amounts of DNA in the first round of 
PCR. Recombination of the HS2 transgenic lines, was detectable using either 
50 ng (HS2-1) or 100 ng (HS2-3, Figure 3B, right) of input DNA, suggesting 
that HS2 is not required for recombination.  Likewise, recombination was 
detectable using 50 ng of DNA when HS3 was deleted. Finally, recombination is 
detectable in all the HS4 lines, except HS4-3 (Figure 3C), suggesting that 
HS4 also is not essential for recombination. Since recombination can be 
detected in the absence of HS2, 3 or 4, this suggests that none of these is 
essential for recombination. 
Notably, mice were obtained with different numbers of copies of the BAC 
transgene. Importantly, however, recombination can be detected when three or 
more copies of the transgene are present, except when HS1 is deleted. This is 
fully consistent with our hypothesis that HS1 is essential for recombination. 
However, whilst hypersensitive sites 2, 3 and 4 are not essential for 
recombination, we are unable to conclude whether they contribute quantitatively 
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to the level of recombination due to the different copy numbers obtained upon 
deletion of these HS.  
 
HS1 contributes to stage-specific recombination  
Immunoglobulin gene rearrangement occurs at distinct stages of B cell 
development with IgH rearrangement occurring first in CD43 positive cells [19]. 
RAG proteins are then down-regulated; the IgH-expressing cells undergo rapid 
proliferation, after which RAG protein expression is up-regulated again in CD43 
negative, small pre-BII cells. Most light chain rearrangement occurs in these 
small pre-BII cells although about 15% occurs in CD43 positive cells. [20]. To 
test if the BAC constructs properly recapitulate stage-specific recombination, 
and to determine which hypersensitive site might be responsible for this stage-
specificity, primary CD43 positive and CD43 negative cells were purified from 
bone marrow by flow cytometry, using CD19 as a pan-B cell marker. The levels 
of DNA were normalised (Figure 4, lower panels) and rearrangement of the Ig 
transgene was then compared to that of the endogenous locus. Since no 
recombination is detectable when HS1 is lost, it is not possible to test directly if 
this hypersensitive site regulates stage-specific recombination. However, 
deletion of either HS3 or HS4 gives the same stage-specific recombination 
pattern as the endogenous locus, namely low levels in CD43+ cells that is 
increased 3-4 fold in CD43- cells (Figure 4). This suggests firstly that the BAC 
constructs recapitulate broad stage-specific pattern of recombination and 
secondly that neither HS3 nor HS4 is required for this specificity. This further 
implies that HS1, that contains all known factor binding sites within E3-1, helps 
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to promote Ig recombination in CD43-/CD19+ cells. Although the different 
stages of CD43- B cells were not separated, it is clear that this enhancer, like 
the Ig 3’ enhancer [21], is sufficient to prevent premature Ig  rearrangement in 
CD43+/CD19+ cells. Moreover, since RAG proteins are primarily expressed in 
small pre-BII cells in the CD43- population, it is likely that E3-1 helps to activate 
recombination at this stage of B cell development. 
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Discussion 
The Ig locus is the smallest antigen receptor locus. Its small size, together with the 
fact that the locus is duplicated, enabled us to generate transgenic mice with a BAC 
encompassing all the unique, potential regulatory elements. Using this system, we 
could not only maintain the correct genomic organisation but also, since the 
hypersensitive sites had been extensively mapped, we could methodically analyse 
their role in regulating lambda locus recombination. We find that the BAC transgene 
undergoes V(D)J recombination with the same broad cell stage specificity as the 
endogenous locus. Systematic analysis of the known hypersensitive sites then 
identified HS1, the 5’ part of E3-1, as being critical for Ig recombination. 
 
Notably, recombination of the BAC occurs at a lower level than the endogenous 
locus.  Thus, although the BAC carries enough information to trigger recombination, 
at least one additional regulatory element seems to be required for full Ig 
recombination.  A good candidate is the E2-4 enhancer, which is 90% homologous to 
HS1 and is bound by the same transcription factors [18]. Indeed, the unrearranged 
Ig locus is organised: V2-Vx-JC2-JC4-E2-4-V1-JC3-JC1-E3-1 [5]. Thus, whilst 
each cluster of two JC genes has its own downstream enhancer, two enhancers 
surround V1-JC3-JC1. Consistent with a role of E2-4 in stimulating rearrangement 
of V1-JC1 and V1-JC3, these rearrangements occur at a higher frequency than 
that of V2-JC2 [22]. These data also raise the possibility that cross talk between 
E3-1 and E2-4, that map >100 kb apart, is required for full chromatin opening and 
activation of Ig recombination.  
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The BAC system offered a significant advantage in that it enabled us to 
unequivocally determine a role for HS1 in activating recombination. Indeed, had this 
analysis been attempted within the full locus (via knock-out studies), or even using 
BAC constructs where E2-4 is present, then the high conservation between E2-4 and 
HS1 [18] would likely have resulted in a reduction in recombination upon deletion of 
HS1 rather than its complete loss. Instead, by analysing just the 3’ half of the locus, 
the essential role of HS1 could be uncovered. 
 
The critical role of HS1 in triggering recombination meant that it was not possible to 
directly test its role in the regulation of stage-specificity of recombination. However, 
deletion studies of HS3 and HS4 showed that neither of these hypersensitive sites 
measurably affects the broad stage-specific recombination pattern. Importantly, loss 
of HS3 or HS4 does not result in premature Ig recombination, implying that E3-1 
could direct recombination to CD43- stages of B cell development. Only two B cell-
specific transcription factors bind to E3-1, PU.1 and IRF4 [23, 24] but notably, the 
levels of these proteins increase by two to three-fold between CD43+ and CD43- B 
cells [25]. Therefore, a plausible hypothesis is that this increase plays an important 
role in activating Ig recombination in CD43- cells.  
 
Together, our data highlight the utility of BAC constructs in transgenic mice to identify 
the elements that regulate Ig V(D)J recombination. Our studies demonstrate that for 
the smallest antigen receptor locus, a single enhancer, HS1 is necessary and 
sufficient to trigger locus opening and recombination over 70 kb. These studies now 
pave the way to examine the mechanism by which this single enhancer triggers long 
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Figure 1: Map of the locus and construct. A) Map of the whole Ig locus [11] and 
B) Map of the BAC construct. A cMyc tag was inserted into C1. Downward arrows 
identify the DNAse I hypersensitive sites.  HsC1 was shown previously not to affect 
Ig transcription [11]. All Apa LI, Not I, Sna BI and Sph I restriction sites are shown, 
but only relevant Bam HI, Eco RI, Bgl II, and Kpn I sites are indicated.  Only two Rsa 
I sites, are shown (in grey) since these were used to locate HS4. The Not I site 
shows the boundary with the BAC sequence. The diagram is largely to scale. 
 
Figure 2: Recombination of the endogenous Ig locus and wild type BAC 
transgene. A) Positions of the PCR primers used to simultaneously detect 
recombination of the endogenous locus and transgenic locus (V1-2/F and C1-2/R). 
The cMyc tag is indicated by a black box. The primers used to generate the Southern 
probe (C1-R3 and C1-F3) are indicated. B) V1-JC1 recombination products, 
derived from the endogenous locus (lower band) and the transgenic wild type BAC 
(upper band), were amplified by semi-quantitative PCR. 1-3 mice from each 
transgenic line were analysed. The DNA was increased by two-fold for one sample 
(wedged arrow) and the product increases proportionately. The uncut PCR product is 
shown. C) Calculated fold difference in recombination of the endogenous Ig locus 
and the wild type BAC.  
 
Figure 3: Deletion of HS1 eliminates Ig recombination. A) Rearrangement of the 
transgene (Tg) was analysed by nested PCR using 50 ng (left) or 200-400 ng (right) 
of spleen DNA from mice carrying wild type (Lanes 1 and 2) or a BAC where HS1 
was deleted. At least two mice were analysed for each line although only a single 
 23 
sample is shown. B) Rearrangement of the transgene using 50 ng (left) or 100 ng 
(right) of spleen DNA from two mice of the HS2 and HS3 lines. C) Rearrangement 
of the transgene using 50 ng (left) or 100-200 ng (right) of spleen DNA from two mice 
of the HS4 lines. The endogenous locus (E) was separately amplified by PCR for 
each sample; it was co-electrophoresed with the transgene PCR as a control. 
 
Figure 4: Loss of HS3 or HS4 does not trigger premature Ig rearrangement A) 
CD43+/CD19+ and CD43-/CD19+ cells were purified from HS3 and HS4 
transgenic lines; the levels of DNA were normalized via PicoGreen and verified by 
amplification of the -globin locus (lower panel). Upper panel: Nested PCR to amplify 
Ig recombination; increasing amounts of sample were used to verify that the product 
increased proportionately to the input DNA. Two to four mice from each transgenic 
line were analysed; representative blots with the average fold increase and standard 
deviations are shown. B) Representative blot of recombination of the endogenous Ig 
locus. A single round of PCR was used to amplify the endogenous locus using the 
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